Innovo Incontinence Device Goes OTC In US, Labeled To Be Worn For 30 Minutes
Executive Summary
Atlantic Therapeutics estimates that one in three women are incontinent, but 60% don’t ask their health care providers about treatment, a statistic that supports offering Innovo OTC less than two years after it launched Rx in the US.